EBS and SABS Related Headlines
Go Back- Emergent BioSolutions signs $50 million manufacturing deal with SAB BIO
- Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142

